Financhill
Back

Canadian Pacific Kansas City Vs. Kymera Therapeutics Industry Stock Comparison

Buy
53

CP
Canadian Pacific Kansas City

Last Price:
77.17
Seasonality Move:
3.66%
Buy
62

KYMR
Kymera Therapeutics

Last Price:
46.17
Seasonality Move:
69.6%
Buy
53
Canadian Pacific Kansas City (CP) is a Buy

Is Canadian Pacific Kansas City a Buy, Sell or Hold?

  • The current Canadian Pacific Kansas City [CP] share price is $78.18. The Score for CP is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • CP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $47.65. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CP Stock Price Chart

What is Canadian Pacific Kansas City's stock price today?

  • The Canadian Pacific Kansas City share price today is $78.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CP is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $47.65
    The current trend is moderately bearish and KYMR is experiencing slight selling pressure.

CP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.48 Sell
Relative Strength Index (14 RSI): 36.61 Sell
Chaikin Money Flow: 785124 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (78.73 - 83.79) Sell
Bollinger Bands (100): (78.25 - 84.17) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.6 Buy
Relative Strength Index (14 RSI): 52.44 Buy
Chaikin Money Flow: -88534 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.05 - 49.09) Buy
Bollinger Bands (100): (36.61 - 48.91) Buy

CP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 78.37 Sell
20-day SMA: 80.28 Sell
50-day SMA: 82.67 Sell
200-day SMA: 82.46 Sell
8-day EMA: 78.6 Sell
20-day EMA: 80.16 Sell
50-day EMA: 81.46 Sell
200-day EMA: 81.2 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.2 Sell
20-day SMA: 46.01 Buy
50-day SMA: 47.06 Buy
200-day SMA: 39.57 Buy
8-day EMA: 47.93 Sell
20-day EMA: 47.19 Buy
50-day EMA: 46.06 Buy
200-day EMA: 39.32 Buy

Canadian Pacific Kansas City Earnings Growth & CP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.55 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

Canadian Pacific Kansas City Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):